AG0039A2

Name: 1-Cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid
Brand: Angene Chemical
SKU: AG0039A2

93106-60-6 | 1-Cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid

Chemical structure of 1-Cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid, CAS 93106-60-6

AG0039A2

SDS

COA

Price

$0.00

Add to Cart

WARNING This product is not for human or veterinary use.

Request For Quotation

CAS Number	93106-60-6
Catalog Number	AG0039A2(AGN-PC-07Y4KD)
Chemical Name	1-Cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid
IUPAC Name	1-cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-4-oxoquinoline-3-carboxylic acid
InChI	InChI=1S/C19H22FN3O3/c1-2-21-5-7-22(8-6-21)17-10-16-13(9-15(17)20)18(24)14(19(25)26)11-23(16)12-3-4-12/h9-12H,2-8H2,1H3,(H,25,26)
InChI Key	SPFYMRJSYKOXGV-UHFFFAOYSA-N
MDL Number	MFCD00792463
Molecular Formula	C19H22FN3O3
Molecular Weight	359.3947
NSC Number	758616
SMILES	C1(CC1)N1C=C(C(C2=CC(=C(C=C12)N1CCN(CC1)CC)F)=O)C(=O)O
UNII	3DX3XEK1BN
Synonyms	Bay Vp 2674, Bay-Vp-2674, Baytril, endrofloxicin, enrofloxacin, Enrofloxacin, 93106-60-6, Baytril, Enrofloxacine, CFPQ, Enrofloxacino, Enrofloxacinum, endrofloxicin, BAY VP 2674, Bay-Vp-2674, Enrofloxacine [French], Enrofloxacinum [Latin], Enrofloxacino [Spanish], UNII-3DX3XEK1BN, Baytril (TN), N-Ethylciprofloxacin, ERFX, 1-cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid, Enrofloxacin [USAN:BAN:INN], HSDB 6952, 1-Cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid, 3DX3XEK1BN, Enrofloxacin (USAN/INN), BRN 5307824, 3-Quinolinecarboxylic acid, 1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo-, MLS000069441, C19H22FN3O3, CHEBI:35720, SPFYMRJSYKOXGV-UHFFFAOYSA-N, MFCD00792463, NCGC00018143-04, AK323592, CPD000059011, PD160788, SMR000059011, 1,4-Dihydro-1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-4-oxo-3-quinolinecarboxylic acid, DSSTox_CID_25619, DSSTox_RID_81007, DSSTox_GSID_45619, 3-Quinolinecarboxylic acid, 1,4-dihydro-1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-4-oxo-, 1-cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-4-oxo-quinoline-3-carboxylic acid, 1-cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-4-oxoquinoline-3-carboxylic acid, 1-cyclopropyl-7-(4-ethylpiperazinyl)-6-fluoro-4-oxohydroquinoline-3-carboxylic acid, 1-Cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-Fluoro-1,4-Dihydro-4-Oxo-3-Quinolonecarboxylic Acid, 1-Cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic Acid, CAS-93106-60-6, CCRIS 8214, Enrofloxacin [USAN:USP:INN:BAN], AC1L2FPD, Opera_ID_1106, BAY-Vp2674, MLS001076496, MLS001424169, CHEMBL15511, SCHEMBL149150, SPECTRUM1503721, DTXSID1045619, KS-00000JRV, HMS2052O09, HMS2090E12, HMS2093I21, HMS2234M11, HMS3373P14, HMS3394O09, HMS3715B18, Pharmakon1600-01503721, ZINC597112, ALBB-030792, BCP15457, HY-B0502, Enrofloxacin, >=98.0% (HPLC), Tox21_110831, BBL009982, DL-384, GA3066, HTS028366, KM3166, NSC758616, s3059, SBB012586, STK711109, AKOS005530685, Tox21_110831_1, AC-7614, AN-8830, AN-8831, API0007273, CCG-101102, CS-2699, KS-5010, MCULE-6446074322, NC00352, NSC-758616, NCGC00018143-01, NCGC00018143-02, NCGC00018143-03, NCGC00018143-05, NCGC00021632-03, CC-27475, H734, SAM001246856, SC-16013, ST072197, ACM1173021925, SBI-0206725.P001, AB0013220, AB1009369, LS-141553, B1742, E0786, FT-0625663, D02473, AB00384269-16, AB00384269_17, AB00384269_18, Enrofloxacin, VETRANAL(TM), analytical standard, 106E606, A844445, C-20873, SR-01000000045, SR-01000000045-3, BRD-K76534306-001-11-0, Enrofloxacin, European Pharmacopoeia (EP) Reference Standard, Enrofloxacin, United States Pharmacopeia (USP) Reference Standard, 1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-4-oxo-3-quinolinecarboxylic acid, Enrofloxacin for system suitability, European Pharmacopoeia (EP) Reference Standard, Enrofloxacin, Pharmaceutical Secondary Standard; Certified Reference Material, 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(4-ethyl-1-piperazinyl)-3-quinoline-carboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(4-ethyl-1-piperazinyl)-3-quinolinecarboxylic acid, 1-Cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid, 9CI, 1-cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoranyl-4-oxidanylidene-quinoline-3-carboxylic acid, Enroxil, Enrofloxacin-d5, Enrofloxacin base, Hipralona ENRO-S, Enrofloxacin hydrochloride, Enrofloxacin [USAN:INN:BAN], CID71188, Enrofloxacin, 98% - 25G 25g, C19-H22-F-N3-O3, ACN-034706, CS-O-01422, 3953B, C052904, D000077422, 112732-17-9,

Complexity	613
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	1
Defined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Exact Mass	359.165g/mol
Formal Charge	0
Heavy Atom Count	26
Hydrogen Bond Acceptor Count	7
Hydrogen Bond Donor Count	1
Isotope Atom Count	0
Molecular Weight	359.401g/mol
Monoisotopic Mass	359.165g/mol
Rotatable Bond Count	4
Topological Polar Surface Area	64.1A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0
XLogP3	-0.2

Related Research Chemicals

CERTIFICATE OF ANALYSIS

Chemical Name:	Batch Number:
Chemical Structure:	CAS Registry No:
	Product ID:
	Manufacture Date:
	Storage Temperature:
	Formula:
	Molecular Weight:
	Quantity:

Analysis Data:

Test:

Result:

Conclusion: The above product meets the specifications of Angene.

Analyst:Chase

Date:

Reviewed by:Jessie

Date:

Angene International Limited

Symbol:
Hazard statements	H303
Precautionary statements